Coupling of vascular CaV1.2 channels in health and disease
血管 CaV1.2 通道在健康和疾病中的耦合
基本信息
- 批准号:10306953
- 负责人:
- 金额:$ 57.91万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2015
- 资助国家:美国
- 起止时间:2015-07-01 至 2025-04-30
- 项目状态:未结题
- 来源:
- 关键词:Active Biological TransportAcuteAddressAdrenergic AgentsAmino AcidsAnimal ModelAnimalsArteriesBiochemistryBlood PressureBlood VesselsBlood flowC-terminalCalcineurinCell NucleusCell physiologyCellsChemosensitizationChronicComplexCoupledCouplingCyclic AMP-Dependent Protein KinasesDataDevelopmentDiabetes MellitusDiffusionDiseaseElectrophysiology (science)Exposure toFosteringFoundationsGene ExpressionGlucoseGoalsHealthHumanIon ChannelKnowledgeLasersLateralMediatingMembraneMembrane ProteinsMicroscopyMissionModelingMolecularMusMuscle CellsMyographyNanoscopyNeuronsOpticsPathologyPhosphorylationPhosphorylation SitePhysiologicalPhysiologyPlayProcessProteinsPublic HealthRegulationRisk FactorsRoleSignal PathwaySignal TransductionSiteSmooth Muscle MyocytesSourceSurfaceTechniquesTestingTherapeuticUnited States National Institutes of HealthVesicleWorkbasediabetic patientexperimental studyextracellularhealth goalsin silicoinnovationnanonanoscalenon-diabeticnovelnovel therapeutic interventionparticlepatch clamppressureresponsetooltraffickingtranscription factor NF-AT c3treatment strategyvasoconstrictionvoltage
项目摘要
Abstract .
How a given protein organizes into a functional complex in health and disease is particularly relevant for
membrane proteins that serve as key information entry points for cells. A suitable and highly relevant example
is voltage-gated L-type CaV1.2 channels, which play a major role in arterial myocyte function and vascular
reactivity. These channels have been shown to gate in unison (i.e. cooperative gating) to amplify Ca2+ influx. At
present, however, a comprehensive understanding of mechanisms fostering the induction of CaV1.2 cooperative
gating as well as its functional implications in health and disease represent major knowledge gaps. The overall
objective of this proposal is to investigate the requirement and physiological consequences whereby
phosphorylation of a single amino acid – S1928 – in the C-terminal of vascular CaV1.2 channels promotes
dynamic spatial organization of CaV1.2 to facilitate cooperative gating at the surface membrane. To accomplish
this goal, we are testing the central hypothesis that CaV1.2 S1928 phosphorylation tunes dynamic channel
clustering and cooperative gating, and that this contributes to modulate vascular function in response to elevated
extracellular glucose and during diabetes. This hypothesis is formulated on the basis of strong and rigorous
preliminary data revealing an unanticipated and remarkable role for S1928 phosphorylation as the culprit for
redistribution and assembly of CaV1.2 subunits into superclusters at the surface membrane of arterial myocytes
upon elevated glucose and diabetes. CaV1.2 superclusters mediated by S1928 phosphorylation promotes
CaV1.2 cooperative gating and Ca2+ influx amplification into arterial myocytes. Key findings that further
underscore the significance of our observations is that CaV1.2 S1928 phosphorylation is necessary for
activation of prohypertensive signaling pathways, vasoconstriction and altered blood flow upon elevated glucose
and during diabetes. Moreover, critical observations have been validated in freshly dissociated human arterial
myocytes from nondiabetic and diabetic patients, underscoring the translational relevance. Emerging and
innovative concepts that will be explored in this application are the role of S1928 phosphorylation as 1) a
rheostat of CaV1.2 function and vascular reactivity and 2) a major risk factor for vascular complications in
diabetes. A multiscale contemporary approach that includes innovative microscopy techniques, sophisticated
biochemistry, electrophysiology, in silico analysis and unique animal models will be implemented to explore the
following aims. Aim 1 is to elucidate the role of S1928 phosphorylation in dynamic CaV1.2 clustering and
cooperative gating upon elevated glucose. Aim 2 is to examine the requirement of S1928 phosphorylation to
induce CaV1.2 superclustering and cooperative gating in arterial myocytes during diabetes. Results will transform
our understanding of how CaV1.2 are organized in arterial myocytes (and perhaps other cells) in health and
disease and may lay the foundation for novel therapeutic strategies with single amino acid accuracy to correct
channel function and vascular reactivity.
抽象的 。
特定蛋白质如何在健康和疾病中组织成功能复合物与以下因素特别相关:
膜蛋白作为细胞的关键信息入口点。一个合适且高度相关的例子
是电压门控 L 型 CaV1.2 通道,在动脉肌细胞功能和血管功能中起主要作用
反应性。这些通道已被证明可以一致门控(即合作门控)以放大 Ca2+ 流入。在
然而,目前对促进 CaV1.2 合作诱导机制的全面了解
门控及其对健康和疾病的功能影响代表了主要的知识差距。整体
该提案的目的是调查需求和生理后果,从而
血管 CaV1.2 通道 C 端单个氨基酸 – S1928 的磷酸化促进
CaV1.2 的动态空间组织促进表面膜的协同门控。为了完成
为了这个目标,我们正在测试 CaV1.2 S1928 磷酸化调节动态通道的中心假设
聚类和协作门控,这有助于调节血管功能以响应升高的
细胞外葡萄糖和糖尿病期间。这个假设是建立在强有力的、严格的基础上的。
初步数据揭示了 S1928 磷酸化作为罪魁祸首的意想不到的显着作用
CaV1.2 亚基重新分布并组装成动脉肌细胞表面膜的超簇
血糖升高和糖尿病。 S1928磷酸化介导的CaV1.2超簇促进
CaV1.2 协同门控和 Ca2+ 流入动脉肌细胞的放大。主要发现进一步
强调我们观察的重要性是 CaV1.2 S1928 磷酸化对于
血糖升高时激活降压信号通路、血管收缩和血流改变
以及糖尿病期间。此外,关键观察结果已在新鲜分离的人类动脉中得到验证。
来自非糖尿病和糖尿病患者的肌细胞,强调了转化相关性。新兴和
本应用中将探讨的创新概念是 S1928 磷酸化的作用:1)
CaV1.2 功能和血管反应性的变阻器以及 2) 血管并发症的主要危险因素
糖尿病。多尺度当代方法,包括创新的显微镜技术、复杂的
将采用生物化学、电生理学、计算机分析和独特的动物模型来探索
以下目标。目标 1 是阐明 S1928 磷酸化在动态 CaV1.2 聚类和
葡萄糖升高时的合作门控。目标 2 是检查 S1928 磷酸化的要求
在糖尿病期间诱导动脉肌细胞中的 CaV1.2 超聚类和协作门控。结果将会改变
我们对 CaV1.2 在健康和健康状况下的动脉肌细胞(或许还有其他细胞)中如何组织的理解
疾病,并可能为具有单氨基酸准确性的新治疗策略奠定基础,以纠正
通道功能和血管反应性。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Manuel F Navedo其他文献
Manuel F Navedo的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Manuel F Navedo', 18)}}的其他基金
Regulation of a cardiac b1AR/SERCA2 complex in heart failure
心力衰竭中心脏 b1AR/SERCA2 复合物的调节
- 批准号:
10641923 - 财政年份:2022
- 资助金额:
$ 57.91万 - 项目类别:
Regulation of a cardiac b1AR/SERCA2 complex in heart failure
心力衰竭中心脏 b1AR/SERCA2 复合物的调节
- 批准号:
10539066 - 财政年份:2022
- 资助金额:
$ 57.91万 - 项目类别:
cAMP signaling in vascular smooth muscle in health and disease
健康和疾病状态下血管平滑肌中的 cAMP 信号传导
- 批准号:
10370716 - 财政年份:2021
- 资助金额:
$ 57.91万 - 项目类别:
cAMP signaling in vascular smooth muscle in health and disease
健康和疾病状态下血管平滑肌中的 cAMP 信号传导
- 批准号:
10532163 - 财政年份:2021
- 资助金额:
$ 57.91万 - 项目类别:
A single amino acid in CaV1.2 controls channel activity and arterial tone in hypertension
CaV1.2 中的单个氨基酸控制高血压中的通道活性和动脉张力
- 批准号:
10392387 - 财政年份:2019
- 资助金额:
$ 57.91万 - 项目类别:
Cerebral Vascular Smooth Muscle Dysfunction in Alzheimer's Disease
阿尔茨海默氏病的脑血管平滑肌功能障碍
- 批准号:
10488479 - 财政年份:2019
- 资助金额:
$ 57.91万 - 项目类别:
Coupling of Vascular Cav1.2 Channels In Health & Disease
健康中血管 Cav1.2 通道的耦合
- 批准号:
8960054 - 财政年份:2015
- 资助金额:
$ 57.91万 - 项目类别:
Coupling of vascular CaV1.2 channels in health and disease
血管 CaV1.2 通道在健康和疾病中的耦合
- 批准号:
10613545 - 财政年份:2015
- 资助金额:
$ 57.91万 - 项目类别:
Coupling of vascular CaV1.2 channels in health and disease
血管 CaV1.2 通道在健康和疾病中的耦合
- 批准号:
10451644 - 财政年份:2015
- 资助金额:
$ 57.91万 - 项目类别:
Calcium sparklets-induced vascular dysfunction during diabetes
糖尿病期间钙火花诱导的血管功能障碍
- 批准号:
7982925 - 财政年份:2010
- 资助金额:
$ 57.91万 - 项目类别:
相似海外基金
Acute senescence: a novel host defence counteracting typhoidal Salmonella
急性衰老:对抗伤寒沙门氏菌的新型宿主防御
- 批准号:
MR/X02329X/1 - 财政年份:2024
- 资助金额:
$ 57.91万 - 项目类别:
Fellowship
Transcriptional assessment of haematopoietic differentiation to risk-stratify acute lymphoblastic leukaemia
造血分化的转录评估对急性淋巴细胞白血病的风险分层
- 批准号:
MR/Y009568/1 - 财政年份:2024
- 资助金额:
$ 57.91万 - 项目类别:
Fellowship
Combining two unique AI platforms for the discovery of novel genetic therapeutic targets & preclinical validation of synthetic biomolecules to treat Acute myeloid leukaemia (AML).
结合两个独特的人工智能平台来发现新的基因治疗靶点
- 批准号:
10090332 - 财政年份:2024
- 资助金额:
$ 57.91万 - 项目类别:
Collaborative R&D
Cellular Neuroinflammation in Acute Brain Injury
急性脑损伤中的细胞神经炎症
- 批准号:
MR/X021882/1 - 财政年份:2024
- 资助金额:
$ 57.91万 - 项目类别:
Research Grant
KAT2A PROTACs targetting the differentiation of blasts and leukemic stem cells for the treatment of Acute Myeloid Leukaemia
KAT2A PROTAC 靶向原始细胞和白血病干细胞的分化,用于治疗急性髓系白血病
- 批准号:
MR/X029557/1 - 财政年份:2024
- 资助金额:
$ 57.91万 - 项目类别:
Research Grant
Combining Mechanistic Modelling with Machine Learning for Diagnosis of Acute Respiratory Distress Syndrome
机械建模与机器学习相结合诊断急性呼吸窘迫综合征
- 批准号:
EP/Y003527/1 - 财政年份:2024
- 资助金额:
$ 57.91万 - 项目类别:
Research Grant
FITEAML: Functional Interrogation of Transposable Elements in Acute Myeloid Leukaemia
FITEAML:急性髓系白血病转座元件的功能研究
- 批准号:
EP/Y030338/1 - 财政年份:2024
- 资助金额:
$ 57.91万 - 项目类别:
Research Grant
STTR Phase I: Non-invasive focused ultrasound treatment to modulate the immune system for acute and chronic kidney rejection
STTR 第一期:非侵入性聚焦超声治疗调节免疫系统以治疗急性和慢性肾排斥
- 批准号:
2312694 - 财政年份:2024
- 资助金额:
$ 57.91万 - 项目类别:
Standard Grant
ロボット支援肝切除術は真に低侵襲なのか?acute phaseに着目して
机器人辅助肝切除术真的是微创吗?
- 批准号:
24K19395 - 财政年份:2024
- 资助金额:
$ 57.91万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Acute human gingivitis systems biology
人类急性牙龈炎系统生物学
- 批准号:
484000 - 财政年份:2023
- 资助金额:
$ 57.91万 - 项目类别:
Operating Grants














{{item.name}}会员




